Article Listing - Protherics sees profit for six-month period

APPOINTMENTS AT XOMA CORP

4 May 1992

US biotechnology company Xoma Corporation has announced the appointment of John Castello as president and chief executive officer. Mr Castello...

SB ACQUIRES GERMAN VACCINES COMPANY

4 May 1992

UK-based pharmaceutical concern SmithKline Beecham has announ-ced its signing of an agreement to acquire Sachsisches Serumwerk. The company is an...

IDEC PHARMA'S RICHARD KRAWIEC

4 May 1992

Richard Krawiec has been appointed as director of investor relations and corporate communications at IDEC Pharmaceutical Corporation.

ROMANIAN HEALTH BUDGET STRIKE

4 May 1992

In Romania, the federation of medical workers' unions, the FSIMR, has threatened to call health service workers out on strike...

BEHRINGWERKE SALES JUMP 15.8%

4 May 1992

The German biological and diagnostic products-manufacturing subsidiary of Hoechst, Behringwerke, saw worldwide sales increase by 15.8% to 1.93 billion Deutschemarks...

ROUSSEL JAPAN CASH INJECTION

4 May 1992

A formal merger between the Roussel-Uclaf and Ajinomoto subsidiary companies on the Japanese drug market has now been signed, creating...

EMIP STUDY BACKS EARLY USE OF EMINASE

4 May 1992

Reporting from the annual meeting of the American College of Cardiology in Dallas, USA, the chief coordinator of the European...

THE UK DRUG INDUSTRYIN REVIEW: 1961-1991

4 May 1992

Addressing a recent Office of Health Economics-sponsored conference in London, UK, entitled A Perspective on Pharmaceutical Econ-omics: 1942-1992, a meeting...

US FDA APPROVABLE LETTER TO PFIZER

4 May 1992

The US Food and Drug Administr-ation has issued an "approvable" letter for Norvasc (amlodipine), a calcium channel blocker for the...

R-PR SALES FALL BUT EARNINGS RISE

4 May 1992

Franco-American pharmaceutical concern Rhone-Poulenc Rorer achieved an increase in net income for the first quarter of 1992 of 55.5% to...

Showing 94311-94320 of 95569 articles